Vestal Point Capital »

Monte Rosa Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.3M 890k 3.74

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Monte Rosa Therapeutics

NEA Management Company
T. Rowe Price Associates
FMR
Baker Bros. Advisors
venBio Select Advisor
Suvretta Capital Management
Vanguard Group
BlackRock
Aisling Capital Management
Alphabet
Citadel Advisors
Vestal Point Capital
Geode Capital Management
State Street Corporation
Sphera Funds Management

View all funds holding Monte Rosa Therapeutics